Tempest Therapeutics's market cap is currently $47.42M. The company's EPS TTM is $-2.07; its P/E ratio is -0.73; Tempest Therapeutics is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-3.27. See an overview of income statement, balance sheet, and cash flow financials.
